日期: 2026年1月12日

SAN DIEGO, Jan 13, 2026 - (ACN Newswire via SeaPRwire.com) - Germany's Federal Office of Bundeswehr Equipment, Information Technology and In-Service Support and the NATO Support and Procurement Agency (NSPA) have announced the procurement of eight MQ-9B SeaGuardian® Remotely Piloted Aircraft (RPA) from General Atomics Aeronautical Systems, Inc. (GA-ASI). The program includes four Certifiable Ground Control Stations. First delivery is expected in 2028.GA-ASI and NSPA signed a contract to purchase eight MQ-9B SeaGuardians for Germany on January 12. From left to right: Allan McLeod, NSPA, Chris Dusseault, GA-ASI, and Joseph Lyden, NSPA.Germany joins a growing list of NATO countries that have selected GA-ASI's advanced MQ-9B RPA for its multi-domain capabilities with exceptionally long range and endurance. The platform provides pole-to-pole satellite control and de-icing capabilities to enable missions in cold climates. SeaGuardian features two multi-mode surface-search radars that deliver wide-area maritime surveillance, with an option to add Anti-Submarine Warfare capability. Additionally, MQ-9B's in-house-developed Detect and Avoid System aids its ability to fly in unsegregated airspace for domestic civilian operations, making it highly versatile for operations from Germany.In 2025, MQ-9B became the first large RPA to obtain a Military Type Certificate from the UK's Military Aviation Authority, certifying its safe operation without geographic restrictions, including over populous areas."We're thrilled that Germany has joined the list of NATO countries that have selected MQ-9B SeaGuardian," said GA-ASI CEO Linden Blue. "The proliferation of MQ-9B in Europe delivers commonality between NATO countries and for Germany, it will provide opportunities for interoperability with their fleet of P-8As."The acquisition negotiation was executed on behalf of Germany by NSPA, which has developed a contractual framework through the MQ-9 Support Partnership (MIC SP) for supporting cooperation amongst its member nations and enabling the procurement of MQ-9B for NATO Allies and Partners. NSPA has added MQ-9B to its portfolio of defense systems to contract on behalf of NATO nations, with the goal of enhancing interoperability for joint training and operations."This Support Partnership demonstrates how NSPA enables efficient, effective and responsive multinational acquisitions for advanced, interoperable capabilities. We are proud to support Germany in this strategic investment for maritime surveillance and security," said Ms. Stacy A. Cummings, NSPA General Manager.MQ-9B includes the SkyGuardian® and SeaGuardian® models as well as the Protector RG Mk1 that is currently being delivered to the United Kingdom's Royal Air Force (RAF). GA-ASI also has MQ-9B procurement contracts with Belgium, Canada, Denmark, India, Japan, Poland, Taiwan and the U.S. Air Force in support of the Special Operations Command and is looking forward to welcoming Germany to that group. MQ-9B has also been featured in various U.S. Navy exercises, including Northern Edge, Integrated Battle Problem, RIMPAC, and Group Sail.About GA-ASIGeneral Atomics Aeronautical Systems, Inc., is the world's foremost builder of Unmanned Aircraft Systems (UAS). Logging more than 9 million flight hours, the Predator® line of UAS has flown for over 30 years and includes MQ-9A Reaper®, MQ-1C Gray Eagle®, MQ-20 Avenger®, and MQ-9B SkyGuardian®/SeaGuardian®. The company is dedicated to providing long-endurance, multi-mission solutions that deliver persistent situational awareness and rapid strike.For more information, visit www.ga-asi.com.Avenger, EagleEye, Gray Eagle, Lynx, Predator, Reaper, SeaGuardian, and SkyGuardian are trademarks of General Atomics Aeronautical Systems, Inc., registered in the United States and/or other countries.Contact:GA-ASI Media RelationsGeneral Atomics Aeronautical Systems, Inc.ASI-MediaRelations@ga-asi.com(858) 524-8101SOURCE: General Atomics Aeronautical Systems, Inc. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

圣地亚哥, 2026年1月13日 - (亚太商讯 via SeaPRwire.com) - 德国联邦国防军装备、信息技术与后勤保障局与北约支持与采购局（NSPA）宣布，将向通用原子航空系统公司（GA-ASI）采购八架MQ-9B海卫士®无人机（RPA）。该项目包含四套可认证地面控制站，首批交付预计于2028年完成。德国加入北约国家行列，成为又一选用通用原子公司先进MQ-9B RPA的成员国。该机型凭借超长航程与续航能力实现多域作战，平台配备极地间卫星控制系统及除冰功能，可执行严寒环境任务。“海卫士”配备两部多模式水面搜索雷达，可执行广域海上监视任务，并可选配反潜作战能力。此外，MQ-9B自主研发的探测规避系统使其具备在非隔离空域执行国内民用任务的能力，为德国境内的行动提供了高度灵活性。2025年，MQ-9B成为首款获得英国军事航空管理局颁发的军用型号认证的大型无人机，该认证确认其可在包括人口稠密区在内的任何地域安全飞行。通用原子航空系统公司首席执行官林登·布鲁表示：“德国加入北约国家选用MQ-9B海卫士的行列令我们倍感振奋。” “MQ-9B在欧洲的普及将提升北约成员国间的通用性，对德国而言，这将为其P-8A机队提供联通互操作的机会。”此次采购谈判由北约支持伙伴关系局（NSPA）代表德国执行。该机构通过MQ-9支持伙伴关系（MIC SP）建立了合同框架，旨在促进成员国间合作，并为北约盟国及伙伴国采购MQ-9B提供支持。NSPA已将MQ-9B纳入其国防系统采购组合，代表北约国家签订合同，旨在提升联合训练与作战行动的互操作性。NSPA总经理斯泰西·A·卡明斯女士表示：“该支持伙伴关系彰显了NSPA如何高效、有效且灵活地推动多国采购先进互操作能力。我们很荣幸支持德国在海上监视与安全领域的战略投资。”MQ-9B系列包含“天卫士”®（SkyGuardian®）与“海卫士”®（SeaGuardian®）型号，以及当前正交付英国皇家空军的“护卫者RG Mk1”（Protector RG Mk1）。通用原子航空系统公司还与比利时、加拿大、丹麦、印度、日本、波兰、台湾地区及美国空军（支持特种作战司令部）签订了MQ-9B采购合同，并期待德国加入该采购联盟。MQ-9B还参与了美国海军多项演习，包括“北方边缘”、‘综合作战演习’、“环太平洋”及“舰队航行”等。关于通用原子航空系统公司通用原子航空系统公司是全球领先的无人机系统制造商。捕食者®系列无人机累计飞行时长逾900万小时，服役超过30年，涵盖MQ-9A死神®、MQ-1C灰鹰®、MQ-20复仇者®及MQ-9B天卫者®/海卫者®机型。公司致力于提供长航时多任务解决方案，实现持续态势感知与快速打击能力。更多信息请访问：www.ga-asi.com  复仇者、鹰眼、灰鹰、山猫、捕食者、死神、海卫士及天卫士均为通用原子航空系统公司在美国及其他国家注册的商标。联系方式：GA-ASI媒体关系部通用原子航空系统公司ASI-MediaRelations@ga-asi.com (858) 524-8101消息来源：通用原子航空系统公司 Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

TAIPEI, TW, Jan 12, 2026 - (ACN Newswire via SeaPRwire.com) - OBI Pharma (4174.TWO) announced that it has entered into a commercial license agreement with TegMine Therapeutics, Inc. (TegMine), a San Francisco-based biopharma focused on developing antibodies targeting cancer-associated glycans and glycoproteins, for a glycan-targeting ADC.Under the terms of the agreement, OBI is eligible to receive an upfront payment as well as development and commercial milestones. Following product launch, OBI will also receive royalties based on a tiered percentage of annual net sales. While the detailed financial terms are not disclosed in accordance with the confidentiality provisions, the overall deal economics are broadly comparable to those of recent similar licensing transactions in the market.TegMine will obtain the exclusive global rights to develop and commercialize the ADC under the license agreement. This international licensing collaboration reflects the potential value of products generated using OBI's Obrion™ ADC technologies.The licensed ADC candidate is derived from a high-affinity anti-glycan antibody provided by TegMine and was developed into an ADC by OBI using the Obrion™ ADC technology family, including the GlycOBI® glycan-conjugation technology, the dual-function enzymatic EndoSymeOBI®, and the highly hydrophilic linker HYPrOBI®. The ADC candidate generated with this proprietary site-specific glycan conjugation is homogeneous and scalable for manufacturing.Heidi Wang, Ph.D. Chief Executive Officer of OBI Pharma, said, "This strategic collaboration leverages the complementary strengths of both organizations. It not only supports the advancement of OBI's ADC product development but also expands opportunities for strategic partnerships using our innovative ADC technologies such as GlycOBI®. We look forward to working closely with TegMine to further develop this novel ADC that may benefit patients with urgent medical needs.""The transition from our successful Master Services Agreement to this global license agreement is a major milestone for TegMine," said Jeff Bernstein, Ph.D., Chief Executive Officer of TegMine Therapeutics. "By combining OBI's site-specific GlycOBI® conjugation with our proprietary antibodies discovered via the TegMiner™ platform, we have generated an ADC with exceptional tumor specificity. This TegMine program demonstrates the power of targeting cancer-specific glycan signatures to deliver potent payloads while sparing healthy tissue. We are excited to advance this program rapidly into the clinic."About GlycOBI®OBI has developed a unique glycan-based ADC technology (GlycOBI®), designed in a Plug and Play format that is compatible with any antibodies, linkers, and payloads, and supports various drug-antibody ratios (DAR). Powered by OBI's proprietary dual-function enzymatic technology EndoSymeOBI® and its hydrophilic linker technology HYPrOBI®, GlycOBI®, a core component of OBI's Obrion™ ADC technology family, enables the generation of site-specific and homogeneous ADCs with an efficient and scalable process under GMP conditions.During the conjugation process, GlycOBI® avoids disrupting the antibody structure and ensures that the resulting ADC retains biophysical characteristics comparable to the native antibody. In addition, OBI's linker technology improves payload conjugation efficiency and reduces the propensity for aggregation or degradation, further supporting a stable and well-controlled ADC manufacturing process. GlycOBI® has overcome limitations commonly associated with traditional ADC approaches and has demonstrated improved antitumor activity and stability in various in vivo studies.About OBI PharmaOBI Pharma is a clinical-stage global oncology company established in 2002 and headquartered in Taiwan. Together with its subsidiary OBI Pharma USA, Inc., the company is dedicated to developing innovative cancer therapeutics to provide new treatment options for patients with urgent medical needs.OBI's research efforts center on novel antibody-drug conjugates (ADC). Through its patented next-generation conjugation technology platform, Obrion™, OBI has established diverse ADC design modalities. The platform integrates proprietary conjugation and linker technologies, including GlycOBI®, GlycOBI DUO®, EndoSymeOBI®, HYPrOBI®, and the novel cysteine-conjugation technology ThiOBI®, to advance next-generation ADC solutions. OBI has developed a next-generation suite of ADC programs. These include monospecific ADCs such as OBI-902 (TROP2) and OBI-904 (Nectin-4); a bispecific single-payload ADC, OBI-201 (HER2 x TROP2); and a bispecific dual-payload ADC, OBI-221 (cMET x HER3). In addition to its ADC programs, OBI's assets include OBI-3424, a first-in-class AKR1C3-targeted small-molecule prodrug that selectively releases a potent DNA-alkylating agent in the presence of the aldo-keto reductase 1C3 enzyme, which is highly expressed in certain tumors. Additional information can be found at www.obipharma.com.GlycOBI®, EndoSymeOBI®, ThiOBI®, HYPrOBI®, and GlycOBI DUO® are registered trademarks of OBI. Obrion™ is a trademark under registration.About TegMine TherapeuticsTegMine is redefining precision oncology by targeting highly expressed glycans and glycoproteins that drive cancer aggressiveness and immune evasion. Our mission is to eradicate cancer by identifying unique tumor antigens that are consistently prevalent across the tumor while being largely absent from healthy tissues. The company's proprietary TegMiner™ platform utilizes glyco-engineered cell lines and advanced mass spectrometry to identify previously inaccessible, cancer-specific glycan epitopes. This discovery engine is designed to generate high-specificity antibodies that deliver maximum therapeutic impact across numerous treatment modalities, including antibody-drug conjugates (ADCs) and other next-generation antibody formats. For more information, please visit www.tegminetx.com.Forward-Looking StatementsStatements included in this press release that are not a description of historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements about future clinical trials, results and the timing of such trials and results. Such risk factors are identified and discussed from time to time in OBI Pharma's reports and presentations, including OBI Pharma's filings with the Taiwan Securities and Futures Bureau.COMPANY CONTACT:Kevin Poulos, Chief Business OfficerOBI Pharma USA, Inc.+1 (619) 537 7698, ext. 102kpoulos@obipharma.comJeff Bernstein, Chief Executive OfficerTegMine Therapeutics, Inc.jeff@tegminetx.comSOURCE: OBI Pharma USA, Inc. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

台北, 2026年1月12日 - (亚太商讯 via SeaPRwire.com) - 台湾浩鼎生技（4174.TWO）宣布，已与 TegMine Therapeutics, Inc.（TegMine）签订商业授权合约，授权开发以醣为靶标的抗体药物复合体（ADC）。TegMine 总部位于美国旧金山、专注于研发癌症相关抗醣或醣蛋白抗体的生技公司。依据合约条款，浩鼎将取得签约金，并可于开发及商业化阶段达成相关里程碑时，获得里程碑付款。产品上市后，浩鼎亦将依年度净销售额按约定比例收取分润权利金。基于保密条款，相关合约细节未予揭露；整体交易金额与近期市场上同类型授权交易大致相当。依授权合约，TegMine 将取得该 ADC 于全球开发与商业化权利。此国际授权合作展现利用浩鼎 Obrion™ ADC 技术所开发之产品深具潜力。此次授权之 ADC 候选药物源自 TegMine 所提供的高亲和力以醣为靶标的单株抗体，由浩鼎运用 Obrion™ ADC 技术中的 GlycOBI® 醣偶联技术、双功能酶 EndoSymeOBI® 与高亲水性连接子 HYPrOBI® 进行开发，采用专一性醣位点偶联技术，打造具均质性并可大量生产。浩鼎执行长王慧君博士表示：「这项策略性合作，充分发挥双方技术优势，不仅有助于推进浩鼎 ADC 产品开发，也积极拓展创新 ADC 技术平台如 GlycOBI® 等策略性合作机会。浩鼎期待与 TegMine 共同开发创新的 ADC，帮助具有迫切医疗需求的癌症病患。」TegMine Therapeutics 执行长 Jeff Bernstein 博士表示：「从成功的 ADC 研发服务合约（Master Services Agreement, MSA）到这次商业授权协议，对 TegMine 而言是一项重要里程碑。透过结合浩鼎的 GlycOBI® 专一性醣位点偶联技术，以及 TegMine™ 平台所开发的专有抗体，我们已开发出具高度肿瘤专一性的 ADC。此计划展现了以癌症特异性醣靶标的开发潜力，在保护正常细胞或组织的同时，有效地传递高活性药物（payloads），实现精准治疗。我们期待加速此计划推进至临床开发阶段。」关于 GlycOBI® 浩鼎所自主开发的醣类 ADC 关键技术平台 GlycOBI®，采用「随插即用」形式，可与任一抗体和药物（payloads）兼容，并适用于多种药物抗体比例（DAR）。在浩鼎专有的酵素技术（EndoSymeOBI®）和连接子技术（HYPrOBI®）搭配下，作为 Obrion™ ADC 技术家族核心组成之一的 GlycOBI®，以高效率且可量产的 GMP 制程，制备具专一性位点与均质的 ADC。GlycOBI® 在偶联过程中，可避免破坏抗体结构，并确保 ADC 与原始抗体具有相似的生物特性。此外，浩鼎的连接子技术可提升药物偶联效率，并降低复合体聚集与降解风险，进一步优化 ADC 制程与品质稳定性。GlycOBI® 已成功克服传统 ADC 技术限制，并在多项动物实验中展现更优越的抗肿瘤活性与结构稳定性。关于浩鼎台湾浩鼎是产品已进展至临床阶段的全球癌症新药开发公司，于 2002 年成立，总部设于台湾。台湾浩鼎与子公司 OBI Pharma USA, Inc. 致力于开发抗癌新药，希望帮助具有迫切医疗需求的癌症患者，提供新的治疗选择。台湾浩鼎的研发核心聚焦于新型抗体药物复合体（Antibody-Drug Conjugates, ADC），透过专利的 Obrion™ 次世代药物偶联技术平台，建立了多元化 ADC 的药物设计模式。此平台整合专有的酵素偶联和连接子技术如 GlycOBI®、GlycOBI DUO®、EndoSymeOBI®、HYPrOBI® 与新型的半胱胺酸偶联技术 ThiOBI® 推进次世代 ADC 开发解决方案。浩鼎已建立下一代 ADC 产品线，其中包含单抗 ADC：OBI-902（TROP2）、OBI-904（Nectin-4）；双抗单药 ADC：OBI-201 (HER2 x TROP2)；以及双抗双药 ADC：OBI-221 (cMET x HER3)。此外，浩鼎的产品线亦包括全球首创 AKR1C3 靶向小分子前驱药 OBI-3424，该药物在肿瘤中高度表达的醛酮还原酶（AKR1C3）作用下，选择性释放强效 DNA 烷基化剂以治疗癌症。更多资讯请参阅：www.obipharma.com。GlycOBI®、EndoSymeOBI®、ThiOBI®、HYPrOBI® 与 GlycOBI DUO® 为浩鼎的注册商标。Obrion™ 为申请中之商标。关于 TegMine Therapeutics TegMine 以高度表现、驱动癌症侵袭性与免疫逃逸的醣与醣蛋白为研究重点，重新定义精准肿瘤治疗。其使命在于根除癌症，并用肿瘤组织中普遍且一致表现的独特肿瘤抗原，其多半不在人体健康组织中表现，以作为推动癌症治疗发展的基础。TegMine 专有的 TegMiner™ 平台结合醣工程化细胞株与先进质谱技术，用以辨识过去难以取得的癌症特异性醣表位。此技术的开发目的在产生具高度专一性的抗体，并可于多种药物设计中发挥最大的治疗潜力，包括抗体药物复合体（ADCs）及其他次世代抗体。更多资讯请参阅：www.tegminetx.comCOMPANY CONTACT: Kevin Poulos, Chief Business Officer OBI Pharma USA, Inc. +1 (619) 537 7698, ext. 102 kpoulos@obipharma.com Jeff Bernstein, Chief Executive OfficerTegMine Therapeutics, Inc.jeff@tegminetx.com  Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

SBX Product Line Will Feature First-Ever AI-Powered Blockchain-Based Age-Gating System for Vape ProductsIKE's patented biometric BLE Bluetooth chip and blockchain-based app will enable Charlie's to ensure that underage individuals will not be able to activate or utilize the Company's age-gated products.The IKE Licensing Agreement provides CHUC with a first mover advantage in youth access prevention (one of the FDA's top priorities) and a three-year exclusivity period for age-gated nicotine analogue products.Charlie's will test market the IKE age-gating system this spring with the Company's popular SBX nicotine analogue product line; simultaneously, Charlie's intends to incorporate the revolutionary technology into its PACHA branded Electronic Nicotine Delivery Systems (ENDS).COSTA MESA, CA, Jan 12, 2026 - (ACN Newswire via SeaPRwire.com) - Charlie's Holdings, Inc. (OTCQB:CHUC) ("Charlie's" or the "Company"), an industry leader in the premium vapor products space, today reported that the Company has signed a definitive licensing agreement with IKE Tech LLC ("IKE") to commercialize the first-ever AI-powered blockchain-based age-gating system for vape products in the United States.E-cigarettes and related vapor products are widely recognized as lower risk alternatives to combustible cigarettes. Accordingly, over the last 15 years, e-cigarette usage in the United States has grown significantly while combustible cigarette smoking rates have dropped. Public health advocates are pleased by this development.80-90% of adult consumers prefer flavored vapor productsBoth the e-cigarette industry and public health officials have come to recognize that 80-90% of adult consumers prefer flavored vapor products over tobacco, menthol, or "clear" flavors and understand that most adult cigarette smokers will continue using traditional combustible products if flavored vapor products are not available. However, operating on the assumption that flavored vapor products can be highly attractive to youth - and that the priority for public health must be the prevention of nicotine usage by underage consumers - to date, the FDA has not authorized for sale in the United States a single flavored vapor product.California, Massachusetts, parts of New York State, and many other regions across the country have also imposed significant restrictions or outright bans on flavored ENDS products. These bans have led to an explosion of illicit foreign products, confusion among retailers, and, most unfortunately, to the elimination of legal flavored products as an option for many adult cigarette smokers who would prefer to switch to far less harmful (flavored) vapes.In this environment, it is apparent that the only way to provide adult smokers with the flavored vapor products that they desire over far more harmful combustible cigarettes, is to "age-gate" flavored vapor products in such a way as to eliminate the possibility that underage consumers can activate or utilize the devices.Numerous companies in the vapor products industry have spent years and millions of dollars on the development of age-gating systems. Most of these systems, however, do not feature "continuous age-gating" (and may, therefore, result in a scenario where the ineffectively age-gated product is purchased by an adult consumer and subsequently used by an underage individual), or the age-gating mechanism is so complex and cumbersome that it renders the device commercially infeasible. Further, to date, no age-gated vapor product has received FDA authorization to be sold in the US market.Continuous age-gating is the only effective means of preventing youth usageCharlie's age-gated SBX Disposable vape - utilizing IKE's patented technology - prevents underage consumers from activating or utilizing the device using BLE-enabled chips and biometric authentication to control the device continuously and in real-time.In a multi-center Human Factors Validation Study designed to evaluate (i) effectiveness in preventing underage access to the ENDS products, (ii) usability, and (iii) safety, results showed:100% of users successfully completed age verification0% of underage users were able to activate a device100% of devices deactivated after a period of inactivity or loss of Bluetooth signal91% rated the app "Extremely Easy" or "Very Easy" to useErrors occurred in only 1% of task attemptsThe results of the Human Factors Validation Study confirm that the IKE age-gating system effectively prevents underage access and provides a highly user-friendly experience for adults. Full findings from the study will be published on clinicaltrials.gov, and the Abstract can be found on https://www.iketech.com/clinical-trials/protocolsCharlie's will test market the IKE age-gating system this spring with a special line of the Company's popular SBX nicotine analogue product; simultaneously, Charlie's intends to incorporate the revolutionary technology into its PACHA branded Electronic Nicotine Delivery Systems (ENDS)."There is a large un-met need for technologies that can satisfy or accommodate concerns the FDA has related to youth access... which means there is a multi-BILLION market opportunity for flavored vapes that are inoperable for underage individuals," explained Henry Sicignano, Charlie's President. "We believe Charlie's could become the first Company to demonstrate to the FDA that age-gated flavored vape products are indeed ‘appropriate for the protection of public health.' Such a success would not only be game changing for Charlie's, but also transformational for the entire industry."John Patterson, President of IKE Tech explained, "IKE is establishing the blueprint for responsible vaping globally. Our agreement with Charlie's represents an industry first in deploying proprietary technologies that protect public health, enable regulatory compliance, and drive sustainable industry growth. We chose to partner with Charlie's because Charlie's non-nicotine SBX product line enables immediate deployment of age-gated technology to the US market, ahead of standard PMTA timelines. This partnership is proof that the industry can bring manufacturers, regulators, and innovators together to protect youth, secure the supply chain, and ensure responsible access for adults.""We believe age-gating is both a responsible business practice as well as a significant competitive advantage for Charlie's," commented Ryan Stump, Charlie's Chief Operating Officer. "By voluntarily age-gating a product that does not require FDA approval, Charlie's will demonstrate to public health officials - and to compliance-minded national convenience store chains - that the Company is absolutely committed to regulatory compliance and youth access prevention."About Charlie's Holdings, Inc.Charlie's Holdings, Inc. (OTCQB:CHUC) is an industry leader in the premium vapor products space. The Company's products are sold around the world to select distributors, specialty retailers, and third-party online resellers through subsidiary company Charlie's Chalk Dust, LLC has developed an extensive portfolio of brand styles, flavor profiles, and innovative product formats.For additional information, please visit Charlie's corporate website at: Chuc.com and the Company's branded online websites: sbxvape.com, CharliesChalkDust.com, enjoypachamama.com, and Pacha.co.About IKE Tech LLCIKE Tech LLC is a joint venture comprised of Ispire Technology Inc., Touch Point Worldwide Inc. d/b/a Berify, and Chemular Inc. IKE is dedicated to advancing next-generation Identity and Age Verification (IAV) systems for ENDS devices. Its patented BLE System-on-a-Chip allows manufacturers to embed customizable, interoperable access controls into vapor devices -ensuring authorized adult use and preventing youth access through real-time mobile and biometric authentication.Safe Harbor StatementThis press release contains "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to statements regarding the Company's overall business, existing and anticipated markets and expectations regarding future sales and expenses. Words such as "expect," "anticipate," "should," "believe," "target," "project," "goals," "estimate," "potential," "predict," "may," "will," "could," "intend," variations of these terms or the negative of these terms, and similar expressions, are intended to identify these forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond the Company's control. The Company's actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to: the Company's ongoing ability to quote its shares on the OTCQB; whether the Company will meet the requirements to up-list to a national securities exchange in the future; the Company's ability to successfully increase sales and enter new markets; whether the Company's PMTA's for its nicotine-containing products will be authorized by the FDA, and the FDA's decisions with respect to the Company's future PMTA's for nicotine products; the Company's ability to manufacture and produce products for its customers; the Company's ability to formulate new products; the acceptance of existing and future products; the complexity, expense and time associated with compliance with government rules and regulations affecting nicotine, synthetic nicotine, products containing nicotine substitutes, and products containing cannabidiol; litigation risks from the use of the Company's products; risks of government regulations; the impact of competitive products; and the Company's ability to maintain and enhance its brands, as well as other risk factors included in the Company's most recent quarterly report on Form 10-Q, annual report on Form 10-K, and other SEC filings. These forward-looking statements are made as of the date of this press release and are based on current expectations, estimates, forecasts and projections as well as the beliefs and assumptions of management. Except as required by law, the Company undertakes no duty or obligation to update any forward-looking statements contained in this release as a result of new information, future events or changes in its expectations.Investors Contact:IR@charliesholdings.comPhone: 949-570-0691SOURCE: Charlie's Holdings, Inc. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

IKE专利生物识别BLE蓝牙芯片与区块链应用程序将确保查理斯旗下年龄门控产品无法被未成年人激活或使用IKE授权协议赋予CHUC在青少年接触防控领域（FDA首要监管重点）的先行者优势，并享有三年期尼古丁替代品年龄门控技术的独家合作权查理公司将于今春通过旗下热销的SBX尼古丁替代品系列试水IKE年龄验证系统；同时计划将这项革命性技术整合至其PACHA品牌的电子烟产品线。加利福尼亚州科斯塔梅萨市, 2026年1月12日 - (亚太商讯 via SeaPRwire.com) - 高端雾化产品领域的行业领导者查理控股公司（OTCQB:CHUC）（以下简称“查理”或“公司”）今日宣布，已与IKE Tech LLC（以下简称“IKE”）签署最终许可协议，将在美国商业化应用首款基于人工智能的区块链年龄验证系统，用于雾化产品。电子烟及相关雾化产品被广泛认可为比传统香烟风险更低的替代品。过去15年间，美国电子烟使用率显著增长，而传统香烟吸烟率持续下降。这一趋势令公共卫生倡导者倍感欣慰。80-90%的成年消费者更偏好调味电子烟产品电子烟行业与公共卫生官员均已认识到，80%-90%的成年消费者更偏好调味雾化产品而非烟草、薄荷或“原味”产品，并理解若无调味雾化产品可供选择，多数成年吸烟者将持续使用传统可燃产品。然而基于“调味雾化产品极易吸引青少年”的假设——且公共卫生首要任务必须是防止未成年人接触尼古丁——迄今美国食品药品监督管理局尚未批准任何调味雾化产品在美国上市销售。加利福尼亚州、马萨诸塞州、纽约州部分地区及全美众多区域也对调味电子烟产品实施了严厉限制或全面禁令。这些禁令导致非法进口产品激增、零售商陷入混乱，最令人遗憾的是，许多本可选择转向危害性低得多的（调味）电子烟的成年吸烟者，如今失去了合法调味产品的替代选项。在此背景下，显然唯有通过“年龄门禁”机制确保未成年人无法激活或使用设备，才能让成年吸烟者获得他们渴望的调味电子烟产品，从而替代危害更严重的传统香烟。电子烟行业众多企业已投入数年时间和数百万美元研发年龄门禁系统。然而，其中大多数系统并未实现“持续年龄验证”（可能导致成年消费者购买后被未成年人使用），或因验证机制过于复杂繁琐而使设备失去商业可行性。此外，迄今为止，尚未有任何带年龄门禁功能的电子烟产品获得美国食品药品监督管理局（FDA）的销售授权。持续年龄门禁是防止青少年使用的唯一有效手段。查理的年龄门禁SBX一次性电子烟——采用IKE专利技术——通过蓝牙芯片和生物识别认证持续实时监控设备，防止未成年消费者激活或使用该设备。一项多中心人因验证研究旨在评估：(i) 防止未成年人接触电子烟产品的有效性，(ii) 设备可用性，以及 (iii) 安全性。研究结果显示：· 100%的用户成功完成年龄验证· 0%的未成年用户能够激活设备· 100%的设备在闲置一段时间或蓝牙信号丢失后自动停用· 91%的用户评价应用“极其简单”或“非常简单”· 仅1%的任务尝试出现错误人因学验证研究结果证实，IKE年龄门禁系统能有效阻止未成年人接触，同时为成年用户提供高度友好的使用体验。完整研究成果将发布于clinicaltrials.gov网站，摘要可查阅https://www.iketech.com/clinical-trials/protocols查理公司将于今春通过旗下热门产品SBX尼古丁替代品的特别系列对IKE年龄验证系统进行市场测试；同时计划将这项革命性技术整合至其PACHA品牌的电子烟产品（ENDS）。查理公司总裁亨利·西奇尼亚诺解释道：“当前亟需能满足FDA对青少年接触电子烟担忧的技术解决方案...这意味着针对未成年人无法使用的调味电子烟存在数十亿美元的市场机遇。” “我们相信查理公司有望成为首家向FDA证明'年龄门控调味电子烟产品确实符合公共卫生保护标准'的企业。此举不仅将改变查理公司的格局，更将推动整个行业转型。”IKE科技总裁约翰·帕特森阐述道："IKE正为全球负责任电子烟行业制定蓝图。我们与查理公司的合作开创了行业先河，通过部署专有技术实现三重目标：保护公共健康、确保合规运营、推动行业可持续发展。选择与Charlie's合作，是因为其无尼古丁SBX产品线能让我们跳过常规PMTA审批周期，率先在美国市场部署年龄门控技术。此次合作证明，行业能够凝聚制造商、监管机构和创新者，共同保护青少年、保障供应链安全，并确保成年人负责任地获取产品。"Charlie's首席运营官Ryan Stump评论道：“我们认为年龄门禁既是负责任的商业实践，也是Charlie's的重要竞争优势。通过主动对无需FDA批准的产品实施年龄门禁，Charlie's将向公共卫生官员及注重合规的全国连锁便利店证明：公司对监管合规和青少年接触预防的坚定承诺。”关于查理控股公司查理控股公司（OTCQB:CHUC）是高端雾化产品领域的行业领导者。公司通过子公司查理粉笔灰有限责任公司（Charlie's Chalk Dust, LLC）向全球精选分销商、专业零售商及第三方在线经销商销售产品，已打造出涵盖丰富品牌风格、风味组合及创新产品形态的完整产品矩阵。更多信息请访问查理斯集团官网：Chuc.com，以及旗下品牌网站：sbxvape.com、CharliesChalkDust.com、enjoypachamama.com和Pacha.co。关于IKE Tech有限责任公司IKE Tech有限责任公司是由Ispire Technology Inc.、Touch Point Worldwide Inc.（以Berify名义运营）以及Chemular Inc.共同组建的合资企业。IKE致力于为电子烟设备开发新一代身份与年龄验证（IAV）系统。其专利蓝牙低功耗系统级芯片（BLE SoC）使制造商能够将可定制、互操作的访问控制嵌入电子烟设备——通过实时移动端与生物特征认证，确保成年人合法使用并阻止未成年人接触。安全港声明本新闻稿包含1995年《私人证券诉讼改革法案》“安全港”条款定义的“前瞻性陈述”，包括但不限于关于公司整体业务、现有及预期市场、未来销售与支出预期的表述。诸如“预期”、“预计”、“应当”、‘相信’、“目标” “规划”、“目标”、“估计”、“潜力”、“预测”、“可能”、“将”、‘能够’、“意图”等词语及其变体或否定形式，以及类似表述均旨在识别此类前瞻性陈述。前瞻性陈述受诸多风险与不确定性制约，其中许多涉及超出公司控制范围的因素或情况。由于多种因素（包括但不限于以下方面），公司实际结果可能与前瞻性陈述所明示或暗示的内容存在重大差异：公司能否持续在OTCQB市场报价；公司未来是否满足升级至全国性证券交易所的要求； 公司能否成功提升销售额并开拓新市场；公司含尼古丁产品的PMTA申请能否获得FDA批准，以及FDA对公司未来尼古丁产品PMTA申请的裁决；公司为客户制造和生产产品的能力；公司研发新产品的能力；现有及未来产品的市场接受度； 遵守涉及尼古丁、合成尼古丁、含尼古丁替代品及含大麻二酚产品的政府法规所涉及的复杂性、成本及时间投入； 因使用本公司产品引发的诉讼风险；政府监管风险；竞争产品影响；以及本公司维护和提升品牌的能力，此外还包括本公司最新季度报告（10-Q表）、年度报告（10-K表）及其他美国证券交易委员会（SEC）备案文件中列明的其他风险因素。本新闻稿中的前瞻性陈述基于管理层当前的预期、估计、预测及假设，截至本新闻稿发布之日有效。除法律要求外，公司无义务因新信息、未来事件或预期变化而更新本新闻稿中的任何前瞻性陈述。投资者联络：IR@charliesholdings.com 电话：949-570-0691消息来源：Charlie's Holdings, Inc. Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, January 12, 2026 - (ACN Newswire via SeaPRwire.com) – Kicking off a brand-new year, the 52nd HKTDC Hong Kong Toys & Games Fair, 17th HKTDC Hong Kong Baby Products Fair and 24th Hong Kong International Stationery & School Supplies Fair, jointly organised by the Hong Kong Trade Development Council (HKTDC) and Messe Frankfurt (HK) Ltd, opened today at the Hong Kong Convention and Exhibition Centre, running over four consecutive days. Highly international in scope, the three fairs are bringing together exhibitors and buyers from around the world, creating networking and business opportunities and helping to foster cross-regional trade cooperation.The Joint Opening Ceremony for the Toys & Games Fair and Baby Products Fair was held this morning, officiated by Hong Kong Special Administrative Region (HKSAR) Government Under Secretary for Commerce and Economic Development Dr Bernard Chan, HKTDC Executive Director Sophia Chong and HKTDC Toys Advisory Committee Chairman Bryant Chan.Jenny Koo, HKTDC Deputy Executive Director, said: “The three fairs, themed ‘New Play for All’, cover three key areas: play, growth and creativity. As Asia’s flagship trade event of its kind, the Toys & Games Fair is tapping into the immense potential of the pop toy and collectibles market. This year, we have launched the new ‘Pop & Play’ pavilion. Open to both trade buyers and the public, the pavilion offers enhanced cross-sector business opportunities, facilitating collaboration and enabling interaction with fans and collectors of designer toys."Ms Koo added: “The three fairs have attracted more than 2,600 exhibitors from 37 countries and regions, including new participants from Bangladesh, New Zealand and Norway, alongside returning exhibitors from Hong Kong, the Chinese Mainland, Asia-Pacific including ASEAN, the Middle East, South Africa, Europe and the United States, presenting a truly international lineup. The HKTDC has organised over 200 buyer missions from more than 40 countries and regions to attend and source products at the fairs. In addition to traditional distributors and importers, we have also invited major e-commerce platforms, importers, department stores, specialty retailers, retail chains and sourcing offices, creating new cross-regional and cross-sector opportunities for the industry."Three fairs reveal multiple product trendsSeveral product trends are emerging from this year's exhibitors, pointing the way forward for the industry to gain a first-mover advantage. These trends include:Pop culture and collectibles toys: The “kidult” and toy collecting markets continue to grow in popularity, injecting strong growth momentum into the toy industry. The “Pop & Play” pavilion brings together some 150 famous local and international IPs – including top names such as B.Duck, CardFun, CR7® LIFE, Hot Toys, LAURA, Moshow Toys, Play Bonito®, Room One, threezero, TUTU MOKEY and more. Some IPs will launch fair premieres and global limited-edition collectibles, including MOMOLAND's debut dolls (Booth: CH-F16); TUTU MOKEY collectible figurines and art sculptures limited to 100 and 88 pieces globally (Booth: CH-F05); CM Concepts Limited's Mazinger Z Playing Cards, limited to 1,500 sets worldwide (Booth: CH-G06); and Dongguan Manbo Brand Management Co., Ltd's Father Joka doll, limited to 100 pieces (Booth: CH-A16).In addition, the Kidult World in Hall 3E will showcase toys catering to adults, including the popular NARUTO Collectible Metal Keychain (Booth: 3E-E13); the officially licensed Transformers Generation One: AMK MINI Series Model Kit (WAVE 3) (Booth: 3E-C02); and a premium jigsaw puzzle from Poland (Booth: 3E-C13).Happy Ageing products in demand: With ageing populations becoming a global reality, toys and games designed specifically for seniors or intergenerational family fun have become a rapidly growing product category. The new Happy Ageing label is being introduced at this year’s Toys & Games Fair to help buyers identify toys and related products for seniors. More than 40 exhibitors will adopt the label and showcase relevant products, including colour-sorting exercises designed by a Hong Kong exhibitor that train muscles in the thumb, index and middle fingers using clips (Booth: 1CON-015); a companion plush toy that alleviates loneliness and soothes emotions for seniors (Booth: 1D-C38); and the DIY Flip Monster from Taiwan (Booth: 1D-C13).Sustainable products stimulate demand: In recent years, more parents have opted for eco-friendly toys to reduce their environmental impact, reflecting the trend for sustainable consumption. In addition to the Green Toys zone at the Toys & Games Fair, both the toys and stationery events employ the Green Solutions label for identification, with more than 400 exhibitors displaying the green leaf logo this year – an increase of approximately 10% compared to 2025.In the Green Toys zone, one exhibitor presents the Beach Life OBP Material Beach Funnel Set crafted from ocean bound plastic (OBP), transforming plastic waste that might otherwise pollute the oceans into delightful and engaging toys, while simultaneously sparking children's boundless creativity and hands-on skills on the beach (Booth: 1C-D02). At the Baby Products Fair, an exhibitor is showcasing baby push walker toys, certified under the FSC and Global Recycling Standard (GRS) and reflecting eco-friendly, sustainable and responsible production practices aligned with forest conservation goals (Booth: 3F-G26).Learning and play combined: Many parents favour products that enhance their children's cognitive, social, intellectual and aesthetic development, enabling learning through play. This trend has driven demand for educational and intellectually stimulating products. At the Toys & Games Fair, a Hong Kong exhibitor is showcasing Canadarm toys (Booth: 1E-C35) that allow children to assemble and operate robotic arms, fostering an interest in machinery while developing grip strength and hand-eye coordination. Another exhibitor is presenting its 2-in-1 Digital Microscope & Telescope, integrating STEM (science, technology, engineering and mathematics) natural sciences into toys (Booth: 1E-A02).Korean film/TV-related products become a new focus: Blending music, action and fashion, the popular animated film KPop Demon Hunters has garnered significant attention. The character Derpy is particularly well-known, with its squishy catering to the growing fanbase for KPop characters (Booth: 1E-B16). The exhibitor also features a replica of the Gonggi Tossing Game featured in Season 2 of Squid Game, bringing to life one of Korea's most iconic childhood games while allowing fans to relive the thrill of the series.Pinkfong, the Korean brand beloved by children for its Baby Shark videos and toys,    makes its debut appearance with the Pinkfong Baby Shark Alphabet Learning Bus, a best-selling early-learning toy that helps preschoolers explore letters and vocabulary (Booth: 1CON-044).Interactive activities and IP development opportunities at “Pop & Play”The inaugural “Pop & Play” pavilion not only showcases trendy toys from around 150 popular IPs but also features a series of interactive elements – including photo opportunities, creative exchanges and autograph sessions – allowing buyers and the public to fully experience the pop toy culture. Activities commenced today with artist Joey Thye sharing her journey from an IP enthusiast and investor to an IP creator during the “IP Walkthrough with Joey Thye” event. Renowned artists and designers will share their creative insights and artistic visions through seminars and autograph sessions, including b.wing, founder of la b.wing Galerie Ltd; Kenny Wong, creator of the iconic Molly and founder of Brothersfree; Steven Choi, founder of Zu and Pi; and Winson Ma, founder and creative director of Winson Classic Creation. On 14 January (Wednesday), in the key thematic seminar titled “Explosive Growth of IP Economy: from Local Success to Global Reach”, Maxim Wang, Head of Toys Category, Alibaba 1688 and Leung Man Lai Lily, CEO and Co-Founder, Nikopicto Limited, will delve into the enormous business opportunities and future trends presented by the collectible toy industry.Mascots Ah Pop and Ah Play will make appearances in the “Pop & Play” pavilion for interactive photo opportunities with visitors. In addition, Hot Toys will showcase eye-catching giant statues including Marvel's Iron Man, Disney's Stitch and Star Wars' Grogu COSBI. threezero will display the giant statue of ROBO-DOU Evangelion 13 from “Evangelion: New Theatrical Edition”, while Asia Partners will exhibit a rare Cristiano Ronaldo autographed jersey and Semk Global Marketing Limited will present its inflatable and fibreglass B.Duck installations.This year’s Toys & Games Fair continues to feature group pavilions from the Chinese Mainland, Taiwan and Korea, as well as the World of Toys Pavilion, featuring selected European exhibitors. The popular Smart-Tech Toys and Games from last year will present toys with smart and AI functions, such as a smart remote-controlled transforming ball operated via smartphone (Booth: 1C-F02) and artificial intelligence (AI) cat dolls (Booth: 1D-A36).Two zones expand at the Baby Products FairAt the Baby Products Fair, the World of Strollers and Gear and ODM Strollers and Gear zones are together hosting approximately 230 exhibitors, with an increase in both exhibitor numbers and fair area compared to last year. The Selection of Europe Pavilion is returning in 2026 together with the Korean and Hong Kong Children, Babies, Maternity Industries Association pavilions.Both the Toys & Games Fair and Baby Products Fair continue to feature the popular Brand Name Gallery, bringing together over 380 well-known brands from around the globe and allowing buyers to source the latest designs and high-quality products from a variety of manufacturers. These include educational toys from Eastcolight at the Toys Fair (Booth: 1E-A02), the Fetchin' Fun Pet Splash Pad (Booth: 1D-B02) and the Claw Crane based on the classic Pac-Man game (Booth: 1E-B20). Meanwhile, the Baby Products Fair features items such as a minimalist, safe pushchair with freely combinable accessories (Booth: 3G-A03).Stationery & School Supplies Fair welcomes New Zealand exhibitor for the first timeJointly organised by the HKTDC and Messe Frankfurt (HK) Ltd, the Hong Kong International Stationery & School Supplies Fair welcomes exhibitors from New Zealand for the first time, showcasing a range of optical magnifiers.  The fair features numerous premium stationery brands, including AP, ChungHwa, Marshmallow, Mirage, Sayyed, SUPERDOTS, TATOU and Toursun offering buyers the latest creative art supplies and stationery gifts.Asia Toys & Games Forum opens tomorrow, revealing global strategic developmentThemed “Empowering the Toy Industry for Global Success”, this year’s Asia Toys & Games Forum has invited international experts to discuss the latest industry updates and developments. It will include sharing on the toys and games market outlook and opportunities by Loo Wee Teck, Global Insights Manager, Toys and Games, Euromonitor International; global IP ecosystem and merchandise strategies by Alex Lin, Vice President and General Manager, Disney Consumer Products, Greater China and Korea, The Walt Disney Company; unlocking product certification for global market access by Phoebe Lee, Global Head – Toys & Juvenile Products, SGS Hong Kong Limited; and exploring the design and business landscape of the seniors toy market in Asia by Yukai Engineering Inc., recipient of multiple international product design awards, and Ageing Asia. Other seminars will cover important topics such as toy safety regulations and regulatory developments, marketing strategies incorporating AI and robotics, and trends in modern childcare and infant products.The three exhibitions offer buyers a unique one-stop sourcing solution, creating more cross-industry business opportunities. Under the EXHIBITION+ model, the fairs combine access to the physical exhibition with the Click2Match smart-matching platform, which enables online business meetings. The online exhibition will be accessible from 5 to 22 January 2026, helping to create more business opportunities for participating companies. Buyers can also scan QR codes at exhibitor booths and display showcases using the Scan2Match function to bookmark their favourite exhibitors, browse product information and engage with exhibitors during and after the fair, helping to build more business connections.Photo download: https://bit.ly/49yRDV6The Hong Kong Toys & Games Fair, Hong Kong Baby Products Fair and Hong Kong International Stationery & School Supplies Fair opened today. The four-day fairs run concurrently from 12 to 15 January at the Hong Kong Convention and Exhibition Centre, bringing together more than 2,600 global exhibitors from 37 countries and regions. The events showcase a high level of internationalisation and help to foster cross-regional business cooperationOfficiating at today’s Joint Opening Ceremony for the Toys & Games Fair and Baby Products Fair are HKTDC Toys Advisory Committee Chairman Bryant Chan (second left), Hong Kong SAR Government Under Secretary for Commerce and Economic Development Dr Bernard Chan (centre), and HKTDC Executive Director Sophia Chong (second right)The “Pop & Play” pavilion debuts at this year’s Toys & Games Fair, featuring around 150 popular international and local IPs. The pavilion is open to industry participants and the wider toy-loving public, providing an ideal platform for business collaboration while fostering interaction between the industry, toy collectors and fansHKSAR Government Under Secretary for Commerce and Economic Development Dr Bernard Chan visited exhibits at the “Pop & Play” pavilion, including a Cristiano Ronaldo autographed jerseyMascots Ah Pop and Ah Play made appearances in the “Pop & Play” pavilion, providing interactive photo opportunities with visitorsThe “Pop & Play” pavilion features multiple photo opportunities, including eye-catching giant statues of Marvel's Iron Man, Disney's Stitch and Star Wars' Grogu COSBI from Hot Toys, a giant statue of ROBO-DOU Evangelion 13 from “Evangelion: New Theatrical Edition”, a rare Cristiano Ronaldo autographed jersey and inflatable and fibreglass B.Duck installationsThis year’s Toys & Games Fair has an impressive pavilion lineup to promote creative products to international buyers, with exhibitors from Hong Kong, the Chinese Mainland, Taiwan and Korea, as well as the World of Toys Pavilion featuring selected European exhibitorsThe Toys & Games and Baby Products Fairs continue to feature the popular Brand Name Gallery, bringing together over 380 well-known brands from around the globeAt the Baby Products Fair, the World of Strollers and Gear and ODM Strollers and Gear zones are together hosting approximately 230 exhibitors, with an increase in both exhibitor numbers and fair area compared to last yearThe Hong Kong International Stationery & School Supplies Fair showcases a range of distinctive productsFair websitesHKTDC Hong Kong Toys & Games Fair: hktoyfair.hktdc.comHKTDC Hong Kong Baby Products Fair: hkbabyfair.hktdc.comHong Kong International Stationery & School Supplies Fair: hkstationeryfair.comRegister for free Pop & Play ticket: https://www.hktdc.com/event/hktoyfair/en/pop-playMedia enquiriesHKTDC’s Communications & Public Affairs Department:Katy WongTel: (852) 2584 4524Email: katy.ky.wong@hktdc.orgWinnie KanTel: (852) 2584 4055Email: winnie.wy.kan@hktdc.orgClayton LauwTel: (852) 2584 4472Email: clayton.y.lauw@hktdc.orgHKTDC Newsroom: http://mediaroom.hktdc.com/enAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in the Chinese Mainland, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Follow us on @hktdc and LinkedIn Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港, 2026年1月12日 - (亚太商讯 via SeaPRwire.com) - 1月8日，联想控股旗下联想之星与君联资本所投手术机器人领军企业精锋医疗（02675.HK）成功登陆港交所，发行价为每股43.24港元，股票代码：2675.HK。这家公司上市首日开盘涨超38%，市值达到230亿港元。精锋医疗成立于2017年，是中国领先的手术机器人公司，是中国首家、全球第二家同时取得多孔腔镜手术机器人、单孔腔镜手术机器人及自然腔道手术机器人注册审批的公司。公司专注于手术机器人及配套器械的研发、生产与销售，产品覆盖泌尿外科、妇科、普外科、胸外科等多科室微创手术需求。精锋医疗亦是国家高新技术企业、国家专精特新"小巨人"企业，曾获2023年度国家科学技术进步奖二等奖。公司在全球共拥有700多项专利及专利申请，其中核心产品超过400项专利，创新突破打破了我国手术机器人领域进口技术的长期垄断。作为一家医疗器械行业的先进手术机器人公司，精锋医疗拥有多孔腔镜手术机器人和单孔腔镜手术机器人。弗若斯特沙利文资料显示，2024年精锋医疗在中国售出20台多孔腔镜手术机器人，在国内制造商中销量排名第一。截至2025年6月30日，公司核心产品全球销售合约量已达61台，并已完成超过14,000例机器人辅助临床手术，产品性能与可靠性得到市场验证。2025年10月，精锋医疗自主研发的精锋单孔腔镜手术机器人SP1000及单多孔手术机器人超级系统MSP2000正式获得欧盟CE认证（MDR）。这标志着全球首个"单多孔一体化"手术机器人平台成功进入国际市场，开启了由中国智慧定义的"全能微创"手术新时代。联想之星：连续出手两次，唯一一家系统布局医疗健康的早期投资机构一路走来，这家由天津大学校友王建辰和高元倩创立的公司得到了联想之星、联想控股、君联资本、红杉中国、博裕投资等众多知名投资者的支持。其中，联控旗下联想之星是股东里面唯一一家系统布局医疗健康领域的早期投资机构。按照230亿港元市值粗略计算，两笔投资已经让联想之星获得了近20倍的账面回报。"精锋医疗成功上市，也使得联想之星在人工智能、机器人领域得到进一步深化。"联想之星总裁、主管合伙人王明耀表示，"人工智能、机器人将持续改造各行各业，手术机器人是其中一个非常好的品类，会发挥越来越大的作用。"在2018年与精锋医疗初次接触，联想之星团队便发现对方在众多方面表现惊艳，但严谨的他们选择进一步调研，迅速启动了对手术机器人赛道的横向扫描与深度研究。通过走访大量医院与专家访谈，以及与业内人士交流，最终构成了他们重注前的信心与基础。感受到这家公司蕴含的发展潜力后，联想之星果断做出投资的决定，并对其追加投资。此后，借助联想之星的投后帮助和创业CEO特训班等资源，精锋医疗的发展得到进一步提速。事实上，在当时果断并坚定地投手术机器人，需要莫大的勇气和决心。能做出如此前瞻性的快速决策，源于联想之星自上而下的打法，先做深入分析，然后再寻找项目。这样的打法，也有赖于此前多年的认知、资源、经验的积累。早在2010年，联想之星便开始关注人工智能的底层技术。到了2015年，联想之星明确了人工智能、机器人会持续改造各行各业，并独立成立了投资小组，当时在硅谷的团队也在该赛道投了几十个项目。正是基于长期且深刻的认知，联想之星在2020年拿出当时一次能给到单个项目的最大金额，并且在下一轮追加投资精锋医疗，成为精锋医疗股东里唯一一家系统性布局医疗健康领域的早期投资机构。骄人成绩的取得，也源于联想之星在医疗健康领域的多年深耕。早在2010年，联想之星便将医疗健康作为重点投资布局的领域之一，成为最早系统布局医疗健康领域的早期投资机构之一。随着优秀的项目越投越多，这家投资机构在医疗健康领域形成了"生物医药"与"数智医疗"两大板块。在联想之星的布局中，生物医药包括创新药、基因技术与服务、诊断与高值耗材等；数智医疗则是利用人工智能、大数据、机器人等技术，对药物研发、医疗器械、医疗服务、保险支付与健康管理等各方面进行升级赋能的机会。随着科创赛道竞争白热化，联想之星表示将选择坚持投更"新"投更"精"。"投更新，是要在行业明确的趋势和拐点到来之前，提前进行预判；投更精，是要在估值上涨的前提下，优中选优。"在王明耀看来，人工智能、机器人、大数据等最新技术与整个医疗产业的结合，实际上蕴含着非常大的机会，"基于联想之星的能力和经验积累，我们未来在医疗健康领域会继续加大投入。"君联资本：与社保基金中关村自主创新专项基金首次迎来投资企业上市联想控股旗下君联资本与社保基金中关村自主创新专项基金（以下简称"社保中关村专项基金"）亦在2024年、2025年三次投资精锋医疗。投资后，君联资本充分发挥在医疗科技领域的深厚产业资源与投后服务能力，在公司战略规划、高端人才引进、全球市场拓展等方面提供了支持，助力公司巩固技术壁垒并加速产品商业化落地。作为中关村"先行先试"改革之一，社保中关村专项基金首次迎来投资企业上市，这一里程碑事件不仅彰显了君联资本在硬科技领域的敏锐洞察力和投资能力，更凸显了长期耐心资本在支持科技创新方面迈出的重要一步。君联资本表示：精锋医疗的成功上市，是其以原创技术突破国际垄断，引领中国手术机器人产业发展的标志性成果。公司凭借全面的产品布局、经临床验证的卓越性能以及快速商业化的能力，不仅在国内市场迅速确立领导地位，更在国际舞台上展现出强大竞争力。期待公司以上市为新起点，持续加大研发创新与生产投入，进一步拓展临床应用与全球市场，赋能全球外科医生与患者，为推动中国高端医疗装备的自主可控与产业升级做出更大贡献。长期以来，君联资本在医疗健康领域进行系统性布局，重点关注生物技术、创新药、医疗器械及AI+医疗等前沿方向。在高端医疗器械与医疗机器人赛道，君联资本表示，将持续看好具备底层技术创新和全球商业化能力的优秀企业。 Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

MIAMI, FL & ABU DHABI, January 12, 2026 – (ACN Newswire via SeaPRwire.com) - The Argentine Football Association (AFA), reigning FIFA World Cup champions, has teamed with Verofax, its exclusive agentic AI partner, to launch Vamos Argentina, an AI-powered fan experience platform designed to transform Argentina's 900+ million fans into micro-influencers, while promoting brands at a fraction of traditional influencer and social marketing costs.Unveiled at a launch event in Miami, Vamos Argentina introduces a unique Digital Media category that lets fans create branded experiences with secure, templated GenAI-driven images and videos featuring Argentine players and matchday scenes (UGC), and instantly post them to their preferred social platforms.Vamos Argentina unlocks a new brand sponsorship channel as well, giving brands the ability to reach 4 billion sports followers, not through advertising, but through GenAI-driven fan experiences featuring brands and products - powered by AFA’s passionate fan pool and Verofax's unique agentic AI technology.Through Vamos Argentina, fans are incentivised to create AI-driven experiences with selfies, official players, videos and memorabilia, with each post integrating brand assets while the platform ensures compliance, brand safety and consistent sponsor visibility across millions of posts.Transforming Fan Passion into Brand InfluenceLeandro Petersen, Chief Marketing Officer of AFA, said: "Our partnership with Verofax opens a new chapter for AFA. Vamos Argentina is a revolutionary platform for fans worldwide to connect through generative AI experiences and drive international growth. It also creates a powerful sponsorship channel, providing brands with a measurable Return on Ad Spend (ROAS) and a repeatable, scalable way to engage with our global AFA fan base."A new chapter for AFA: Verofax CEO Wassim Merheby, Argentina Head Coach Lionel Scaloni and AFA Marketing Chief Leandro Petersen launching Vamos Argentina in Miami.Wassim Merheby, CEO of Verofax, added: "AFA is pioneering official GenAI experiences as a new channel for brand sponsors. By training AI engines on players, we deliver authentic AI-powered experiences featuring sponsors' brands at a fraction of the cost of traditional approaches. With over 100M AFA followers, 250-500M match viewers and 900M combined player followers, Vamos Argentina offers unprecedented reach and engagement."Targeted, Scalable, and MeasurableLive demos at the launch event showcased how fans can become micro-influencers in seconds. With a single photo, the AI creates immersive moments featuring real players, official kits, AFA backdrops, and branded product placements - ready for instant sharing. Each post carries sponsor branding, amplifying authentic fan-driven content across social networks.Sponsors benefit from guaranteed fan posts per brand campaign, reaching millions of targeted sports followers at unmatched CPM rates compared to traditional influencer marketing. Campaigns are fully managed by Verofax, with gamified fan experiences and incentives such as VIP tickets, signed merchandise, and exclusive meet-and-greets to drive participation and engagement.Opportunities Ahead of World Cup 2026With limited sponsorship slots available, AFA will begin promoting Vamos Argentina packages in January 2026, supported by a global marketing campaign to activate fans worldwide. To learn more about sponsoring AFA's AI-powered fan experiences featuring your brand and products, visit https://afa.verofax.com.About the Argentine Football Association (AFA)The Argentine Football Association (AFA) is the governing body of football in Argentina, overseeing national competitions and representing the country worldwide. Home to the reigning FIFA World Cup champions, AFA commands one of the most passionate fan bases worldwide. Visit www.afa.com.ar.About VerofaxFounded in 2019, Verofax is a leading AI technology company delivering next-generation customer, sponsor and fan engagement solutions. Trusted by Fortune 100 brands including AB InBev, FC Barcelona, Emirates Airlines and Microsoft, Verofax operates in over 50 markets, providing agentic AI experiences and holographic display solutions (Holobox) for interactive engagement. Learn more at www.verofax.com/afa or contact info@verofax.comContactNeha Sharma, neha.sharma@verofax.com, Sadra Azzi, info@verofax.com, Tel: +1 323 304 0626Verofax is social! Follow Verofax on Facebook, LinkedIn, YouTube, Instagram and x.-----Argentine Football Association (AFA) Argentine National Team (La Albiceleste)#Argentina #SeleccionArgentina #VamosArgentina #AFA #Albiceleste #LaAlbiceleste #TodosJuntos #ElijoCreer #CampeonesDelMundo #Scaloneta@afa @afaseleccion Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

迈阿密 & 阿布扎比, 2026年1月12日 - (亚太商讯 via SeaPRwire.com) - 阿根廷足球协会（Argentine Football Association，AFA），现任 FIFA 世界杯冠军，与 Verofax 达成合作，后者成为其独家 AI 合作伙伴，共同推出 Vamos Argentina —— 一个由 AI 驱动的球迷互动体验平台，旨在将阿根廷超过 9 亿名球迷转化为微型影响者（micro influencers），同时以远低于传统网红营销和社交媒体推广成本的方式为品牌赋能。Vamos Argentina 于迈阿密举行的发布活动上正式亮相。该平台开创了一个全新的数字媒体类别，使球迷能够通过安全、模板化、由生成式 AI（GenAI）驱动的图像和视频，创作包含阿根廷球员及比赛日场景的品牌化内容（UGC），并可即时发布至其偏好的社交媒体平台。Vamos Argentina 同时开辟了一个全新的品牌赞助渠道，使品牌能够触达 40 亿体育内容关注者——并非通过传统广告形式，而是通过由 GenAI 驱动、融合品牌与产品的球迷互动体验实现传播。该模式由 AFA 球迷社群的高度热情与 Verofax 独有的 agentic AI 技术共同驱动。通过 Vamos Argentina，平台激励球迷围绕阿根廷球员创作互动体验内容，包括自拍、视频以及体育知识类游戏；每一次内容发布均无缝整合品牌素材，同时平台确保合规性、品牌安全，并在数以百万计的内容发布中维持赞助商曝光的一致性与可控性。将球迷热情转化为品牌影响力AFA 首席营销官 Leandro Petersen 表示：“我们与 Verofax 的合作为 AFA 开启了全新篇章。Vamos Argentina 为全球球迷提供了一种通过独特 AI 体验实现互动的全新方式，推动了国际化增长。同时，该平台也打造了一个极具影响力的赞助渠道，为品牌提供可衡量的广告支出回报率（Return on Ad Spend，ROAS），并以可复制、可扩展的方式，与我们遍布全球的球迷群体建立深度互动。”Verofax 首席执行官 Wassim Merheby 补充表示：“AFA 正在率先将官方 GenAI 体验打造为品牌赞助商的全新合作渠道。通过基于球员进行 AI 引擎训练，我们能够以远低于传统成本的方式，交付融合赞助商品牌的真实 AI 驱动体验。凭借 AFA 超过 1 亿名关注者、2.5 亿至 5 亿场均观赛人群，以及球员合计 9 亿名粉丝规模，Vamos Argentina 提供了前所未有的覆盖范围与互动能力。”精准、可扩展、可衡量在发布活动现场进行的现场演示展示了球迷如何在数秒之内成为微型影响者。只需一张照片，AI 即可生成沉浸式互动场景，内容涵盖真实球员、官方球衣、AFA 专属背景以及品牌化产品植入，并可即时分享至社交平台。每一条内容均承载赞助商品牌标识，在各大社交网络中放大由球迷自发驱动的真实内容传播力。对于赞助商而言，该平台可为每一项品牌营销活动提供有保障的球迷内容发布量，以远低于传统网红营销的 CPM 成本，触达数以百万计的精准体育内容关注者。所有营销活动均由 Verofax 进行全流程管理，并通过游戏化的球迷互动体验及激励机制（包括 VIP 门票、签名纪念品及专属见面会）推动球迷参与度与互动深度。2026 年世界杯前的限量合作机会鉴于赞助名额有限，AFA 将于 2026 年 1 月 起正式推广相关赞助方案，并通过一项全球整合营销活动，激活遍布全球的球迷群体。如需了解如何赞助 AFA 推出的、融合您品牌与产品的 AI 驱动球迷互动体验，请访问： https://afa.verofax.com  关于 Argentine Football Association (AFA)Argentine Football Association (AFA) 是阿根廷足球的官方管理机构，负责监管国内各级足球赛事，并在全球范围内代表阿根廷参赛。作为现任 FIFA 世界杯冠军 的所属机构，AFA 拥有全球最具热情与影响力的球迷群体之一。更多信息请访问：www.afa.com.ar  关于 VerofaxVerofax 成立于 2019 年，是一家领先的 AI 科技公司，致力于提供下一代客户、赞助商及球迷互动解决方案。Verofax 深受包括 AB InBev、FC Barcelona、Emirates Airline 和 Microsoft 在内的多家《财富》100 强企业信赖，业务覆盖 50 多个市场，提供 Agentic AI 互动体验 及 全息显示解决方案（Holobox），用于打造高度沉浸式的互动体验。了解更多信息，请访问：www.verofax.com/afa ，或联系 info@verofax.com联系方式Neha Sharma, neha.sharma@verofax.com, Sadra Azzi, info@verofax.com, 电话: +1 323 304 0626Verofax is social! Follow Verofax on Facebook, LinkedIn, YouTube, Instagram and x. Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com